Current Saline Shortage

Saline Shortage

The current nationwide saline shortage has the potential to negatively impact rheumatology patients dependent on infusible products to manage their disease. Bags of normal saline (0.9%) in the 250ml-1000ml volumes are especially low.

OTREXUP™ (methotrexate) injection approved by the FDA

Methotrexate Injection Approved by FDA

OTREXUP™ (methotrexate) injection was recently approved by the U.S. Food and Drug Administration.

It is indicated for adults with severe, active rheumatoid arthritis, or children with active polyarticular juvenile idiopathic arthritis who have failed first line therapies. It is also indicated for severe, recalcitrant, disabling psoriasis.